Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-09-30 Option Award | 2020-10-06 3:20 pm | N/A 2025-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Dickason David SVP of Pre-Clinical Prod. Dev. | 2,000,000 | $0 | 2,000,000 (Direct) | View |
| 2020-09-30 Other | 2020-10-02 3:51 pm | 2020-09-30 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Jones Timothy L. CEO and President | 28 | $0 | 8,818,154 (Direct) | View |
| 2020-09-30 Conversion | 2020-10-02 3:51 pm | 2020-09-30 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Jones Timothy L. CEO and President | 4,409,091 | $0 | 8,818,154 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 3:50 pm | N/A 2025-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | MacFarlane Katie Director | 5,000,000 | $0 | 5,000,000 (Direct) | View |
| 2020-09-30 Other | 2020-10-02 3:47 pm | 2020-09-30 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman & CSO | 100 | $0 | 100 (Direct) | View |
| 2020-09-30 Gift | 2020-10-02 3:47 pm | 2020-09-30 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman & CSO | 200 | $0 | 100 (Direct) | View |
| 2020-09-30 Other | 2020-10-02 3:47 pm | 2020-09-30 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner | 150 | $0 | 107,048,556 (Direct) | View |
| 2020-09-30 Gift | 2020-10-02 3:47 pm | 2020-09-30 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner | 300 | $0 | 107,048,556 (Direct) | View |
| 2020-09-30 Conversion | 2020-10-02 3:47 pm | 2020-09-30 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner | 101,905,382 | $0 | 107,048,556 (Indirect) | View |
| 2020-07-31 Option Award | 2020-08-04 2:28 pm | N/A 2025-07-31 | RespireRx Pharmaceuticals Inc. | RSPI | MacFarlane Katie Director | 7,500,000 | $0 | 7,500,000 (Direct) | View |
| 2020-07-31 Option Award | 2020-08-04 2:25 pm | N/A 2025-07-31 | RespireRx Pharmaceuticals Inc. | RSPI | Purcell Richard David Jr. SVP - Research and Development | 5,000,000 | $0 | 5,000,000 (Direct) | View |
| 2020-07-31 Option Award | 2020-08-04 2:21 pm | N/A 2025-07-31 | RespireRx Pharmaceuticals Inc. | RSPI | Jones Timothy L. CEO and President | 17,000,000 | $0 | 17,000,000 (Direct) | View |
| 2020-07-13 Other | 2020-07-15 9:14 pm | 2020-07-13 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman, CEO & CSO | 600 | $0 | 600 (Direct) | View |
| 2020-07-13 Gift | 2020-07-15 9:14 pm | 2020-07-13 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman, CEO & CSO | 1,200 | $0 | 600 (Direct) | View |
| 2020-07-13 Other | 2020-07-15 6:13 pm | 2020-07-13 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner | 500 | $0 | 1,075 (Direct) | View |
| 2020-07-13 Gift | 2020-07-15 6:13 pm | 2020-07-13 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner | 1,000 | $0 | 1,075 (Direct) | View |
| 2020-03-22 Other | 2020-03-24 4:48 pm | N/A N/A | RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secretary & Teasurer 10% Owner | 4,500,000 | $0 | 4,640,589 (Direct) | View |
| 2020-03-22 Gift | 2020-03-24 4:48 pm | N/A N/A | RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secretary & Teasurer 10% Owner | 4,375,000 | $0 | 4,640,589 (Direct) | View |
| 2020-03-22 Other | 2020-03-24 4:20 pm | N/A N/A | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman, CEO, CSO | 4,500,000 | $0 | 4,500,598 (Direct) | View |
| 2020-03-22 Gift | 2020-03-24 4:20 pm | N/A N/A | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman, CEO, CSO | 4,500,000 | $0 | 4,500,598 (Direct) | View |